Merit Medical To Present 6-Month Outcomes From Randomized Arm Of WRAPSODY Arteriovenous Access Efficacy Pivotal Study At Two Upcoming Medical Meetings
Portfolio Pulse from Benzinga Newsdesk
Merit Medical Systems, Inc. (NASDAQ:MMSI) will present six-month outcomes from its WAVE study on the WRAPSODY Endoprosthesis for treating stenosis in the venous outflow circuit at upcoming medical meetings. The study involves 245 patients with arteriovenous fistula and 113 with arteriovenous graft, comparing WRAPSODY to standard care.
August 01, 2024 | 8:48 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Merit Medical Systems will present six-month outcomes from its WAVE study on the WRAPSODY Endoprosthesis, which could influence investor sentiment positively if results are favorable.
The presentation of six-month outcomes from the WAVE study at medical meetings could positively impact MMSI's stock price if the results demonstrate significant safety and efficacy of the WRAPSODY Endoprosthesis. This could enhance investor confidence in the company's product pipeline and future revenue potential.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100